Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name THAR PHARMACEUTICALS INC Proposed Ticker THAR CUSIP N/A Business Description A clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, oral therapies designed to solve clinical limitations of existing intravenous-only therapies for serious and life threatening conditions Lead Underwriter SunTrust Robinson Humphrey, Inc Co-Managers N/A Initial Shares N/A Revised Initial Shares N/A Initial Price N/A Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.